DK1592407T3 - Indretning med depotvirkning og fremgangsmåde til okulær indgivelse af carbonanhydraseinhibitorer - Google Patents
Indretning med depotvirkning og fremgangsmåde til okulær indgivelse af carbonanhydraseinhibitorerInfo
- Publication number
- DK1592407T3 DK1592407T3 DK04704793.1T DK04704793T DK1592407T3 DK 1592407 T3 DK1592407 T3 DK 1592407T3 DK 04704793 T DK04704793 T DK 04704793T DK 1592407 T3 DK1592407 T3 DK 1592407T3
- Authority
- DK
- Denmark
- Prior art keywords
- carbonic anhydrase
- ocular administration
- anhydrase inhibitors
- depot effect
- depot
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00772—Apparatus for restoration of tear ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/432—Inhibitors, antagonists
- A61L2300/434—Inhibitors, antagonists of enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Nanotechnology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44249903P | 2003-01-24 | 2003-01-24 | |
| US48267703P | 2003-06-26 | 2003-06-26 | |
| US48331603P | 2003-06-26 | 2003-06-26 | |
| US50197503P | 2003-09-11 | 2003-09-11 | |
| PCT/US2004/001719 WO2004066980A2 (en) | 2003-01-24 | 2004-01-23 | Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1592407T3 true DK1592407T3 (da) | 2010-04-19 |
Family
ID=32831099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04704793.1T DK1592407T3 (da) | 2003-01-24 | 2004-01-23 | Indretning med depotvirkning og fremgangsmåde til okulær indgivelse af carbonanhydraseinhibitorer |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1592407B1 (da) |
| JP (1) | JP2006516619A (da) |
| KR (1) | KR20050108345A (da) |
| AR (1) | AR043356A1 (da) |
| AT (1) | ATE451915T1 (da) |
| AU (1) | AU2004207507B2 (da) |
| BR (1) | BRPI0406880A (da) |
| CA (1) | CA2513752C (da) |
| DE (1) | DE602004024642D1 (da) |
| DK (1) | DK1592407T3 (da) |
| ES (1) | ES2338420T3 (da) |
| MX (1) | MXPA05007718A (da) |
| SI (1) | SI1592407T1 (da) |
| TW (1) | TWI345987B (da) |
| WO (1) | WO2004066980A2 (da) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050048099A1 (en) * | 2003-01-09 | 2005-03-03 | Allergan, Inc. | Ocular implant made by a double extrusion process |
| AU2005247122C1 (en) | 2004-04-30 | 2012-02-02 | Eyegate Pharma S.A. | Irritation-reducing ocular iontophoretic device |
| FR2869531B1 (fr) * | 2004-04-30 | 2006-07-14 | Optis France Sa Sa | Dispositif de iontophorese oculaire diminuant les irritations |
| WO2006031658A2 (en) * | 2004-09-10 | 2006-03-23 | Allergan, Inc. | Therapeutic lacrimal canalicular inserts and related methods |
| US20060110429A1 (en) * | 2004-11-24 | 2006-05-25 | Therakine Corporation | Implant for intraocular drug delivery |
| JP4872076B2 (ja) * | 2005-09-15 | 2012-02-08 | 国立大学法人 長崎大学 | 硝子体可視化剤 |
| EP2004172B1 (en) * | 2006-03-31 | 2019-03-13 | Mati Therapeutics Inc. | Drug delivery structures and compositions for nasolacrimal system |
| US9474645B2 (en) | 2006-06-21 | 2016-10-25 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
| SG138567A1 (en) * | 2006-06-21 | 2008-01-28 | Johnson & Johnson Vision Care | Punctal plugs for the delivery of active agents |
| US9173773B2 (en) * | 2006-06-21 | 2015-11-03 | Johnson & Johnson Vision Care, Inc. | Punctal plugs for the delivery of active agents |
| US20080045911A1 (en) * | 2006-06-21 | 2008-02-21 | Borgia Maureen J | Punctal plugs for the delivery of active agents |
| UY30883A1 (es) | 2007-01-31 | 2008-05-31 | Alcon Res | Tapones punctales y metodos de liberacion de agentes terapeuticos |
| AU2008300013A1 (en) * | 2007-09-07 | 2009-03-19 | Qlt Inc. | Drug cores for sustained release of therapeutic agents |
| US20100158980A1 (en) * | 2008-12-18 | 2010-06-24 | Casey Kopczynski | Drug delivery devices for delivery of therapeutic agents |
| ES2679673T3 (es) | 2008-12-31 | 2018-08-30 | Eyegate Pharmaceuticals, Inc. | Sistema para iontoforesis ocular con amortiguación |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| CA3186189A1 (en) | 2009-05-18 | 2010-11-25 | Dose Medical Corporation | Drug eluting ocular implant |
| CA2798084A1 (en) * | 2010-05-17 | 2011-11-24 | Aerie Pharmaceuticals, Inc. | Drug delivery devices for delivery of ocular therapeutic agents |
| US9668915B2 (en) | 2010-11-24 | 2017-06-06 | Dose Medical Corporation | Drug eluting ocular implant |
| US8349005B2 (en) | 2011-01-03 | 2013-01-08 | Masatoshi Murata | Method for burying implant to choroid |
| WO2013011511A1 (en) | 2011-07-18 | 2013-01-24 | Mor Research Applications Ltd. | A device for adjusting the intraocular pressure |
| US9173775B2 (en) | 2012-03-26 | 2015-11-03 | Glaukos Corporation | System for delivering multiple ocular implants |
| US10517759B2 (en) | 2013-03-15 | 2019-12-31 | Glaukos Corporation | Glaucoma stent and methods thereof for glaucoma treatment |
| US11925578B2 (en) | 2015-09-02 | 2024-03-12 | Glaukos Corporation | Drug delivery implants with bi-directional delivery capacity |
| WO2017053885A1 (en) | 2015-09-25 | 2017-03-30 | Glaukos Corporation | Punctal implants with controlled drug delivery features and methods of using same |
| JP7009384B2 (ja) * | 2016-04-05 | 2022-01-25 | フォーサイト・ビジョン フォー・インコーポレーテッド | 移植可能な眼薬送達デバイス |
| EP3453366A4 (en) * | 2016-05-06 | 2020-01-08 | Public University Corporation Nagoya City University | DEVICE FOR DELAYED RELEASE OF AN OPHTHALMIC ACTIVE SUBSTANCE |
| US11376040B2 (en) | 2017-10-06 | 2022-07-05 | Glaukos Corporation | Systems and methods for delivering multiple ocular implants |
| EP3773330B1 (en) * | 2018-03-29 | 2025-03-05 | Mati Therapeutics Inc. | Ophthalmic drug sustained release formulation and uses for dry eye syndrome treatment |
| EP4210682B1 (en) * | 2020-09-14 | 2026-03-25 | EyePoint, Inc. | Bioerodible ocular drug delivery insert and therapeutic method |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
| US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
| US6196993B1 (en) * | 1998-04-20 | 2001-03-06 | Eyelab Group, Llc | Ophthalmic insert and method for sustained release of medication to the eye |
| US6375972B1 (en) * | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| EP1404297B1 (en) * | 2001-06-12 | 2011-04-27 | The Johns Hopkins University School Of Medicine | Reservoir device for intraocular drug delivery |
| CA2513751C (en) * | 2003-01-24 | 2012-01-10 | Control Delivery Systems, Inc. | Sustained release device and method for ocular delivery of adrenergic agents |
-
2004
- 2004-01-23 WO PCT/US2004/001719 patent/WO2004066980A2/en not_active Ceased
- 2004-01-23 ES ES04704793T patent/ES2338420T3/es not_active Expired - Lifetime
- 2004-01-23 MX MXPA05007718A patent/MXPA05007718A/es active IP Right Grant
- 2004-01-23 BR BR0406880-7A patent/BRPI0406880A/pt not_active IP Right Cessation
- 2004-01-23 AR ARP040100202A patent/AR043356A1/es unknown
- 2004-01-23 JP JP2006502934A patent/JP2006516619A/ja active Pending
- 2004-01-23 EP EP04704793A patent/EP1592407B1/en not_active Expired - Lifetime
- 2004-01-23 AU AU2004207507A patent/AU2004207507B2/en not_active Ceased
- 2004-01-23 SI SI200431353T patent/SI1592407T1/sl unknown
- 2004-01-23 DE DE602004024642T patent/DE602004024642D1/de not_active Expired - Lifetime
- 2004-01-23 CA CA2513752A patent/CA2513752C/en not_active Expired - Fee Related
- 2004-01-23 DK DK04704793.1T patent/DK1592407T3/da active
- 2004-01-23 KR KR1020057013640A patent/KR20050108345A/ko not_active Ceased
- 2004-01-23 AT AT04704793T patent/ATE451915T1/de not_active IP Right Cessation
- 2004-01-27 TW TW093101756A patent/TWI345987B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2513752A1 (en) | 2004-08-12 |
| AR043356A1 (es) | 2005-07-27 |
| AU2004207507A1 (en) | 2004-08-12 |
| SI1592407T1 (sl) | 2010-04-30 |
| EP1592407A2 (en) | 2005-11-09 |
| ES2338420T3 (es) | 2010-05-07 |
| KR20050108345A (ko) | 2005-11-16 |
| TWI345987B (en) | 2011-08-01 |
| CA2513752C (en) | 2012-01-03 |
| WO2004066980A3 (en) | 2004-09-16 |
| JP2006516619A (ja) | 2006-07-06 |
| ATE451915T1 (de) | 2010-01-15 |
| TW200505507A (en) | 2005-02-16 |
| WO2004066980A2 (en) | 2004-08-12 |
| DE602004024642D1 (de) | 2010-01-28 |
| EP1592407B1 (en) | 2009-12-16 |
| BRPI0406880A (pt) | 2006-01-03 |
| AU2004207507B2 (en) | 2009-11-19 |
| MXPA05007718A (es) | 2005-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1592407T3 (da) | Indretning med depotvirkning og fremgangsmåde til okulær indgivelse af carbonanhydraseinhibitorer | |
| DK1592408T3 (da) | Indretning med depotvirkning og fremgangsmåde til okulær indgivelse af adrenergt midler | |
| DK1539115T3 (da) | Fremgangsmåder og doseringsformer til kontrolleret levering af paliperidon | |
| ATE410421T1 (de) | P38 inhibitor und anwendungsverfahren dafür | |
| DK1628530T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse og behandling af sepsis | |
| IS8037A (is) | P38-hindrar og aðferðir til notkunar þeirra | |
| NO20055211D0 (no) | Anti-fungale forbindelser og fremgangsmater for anvendelse | |
| DE602004002520D1 (de) | Tragbares Endgerät und Verfahren zum GPS-Zeit festhalten | |
| DK1827274T3 (da) | Kryokirurgiindretning og fremgangsmåde til afgivelse af et flydende kølemiddel | |
| DE602004031527D1 (de) | Kombination von serotonin-wiederaufnahme-hemmern und agomelatin | |
| NO20053874L (no) | Formulering og metoder for behandling av thrombocytemi | |
| DK1364691T3 (da) | Forlystelsesindretning og fremgangsmåde til anvendelse af en forlystelsesindretning | |
| DK1819489T3 (da) | Indretning og fremgangsmåde til portionering | |
| DK1362864T3 (da) | Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| DK1836480T3 (da) | Fremgangsmåde og anordning til bestemmelse af røgpunktet for carbonhydrider | |
| DK2457582T3 (da) | Fremgangsmåde og sammensætningertil kontrol af ektoparasitter | |
| DE60326030D1 (de) | Navigationsgerät und -verfahren | |
| DK1380590T3 (da) | Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| NO20034208L (no) | Anordning og fremgangsmåte for bölgedemping | |
| DE50204877D1 (de) | Einrichtung und Verfahren zur Strahlbehandlung von Kanalinnenwänden | |
| DE50301297D1 (de) | Schiebevorrichtung und verfahren zum verschieben | |
| NO20020261D0 (no) | Anordning og fremgangsmåte for testing | |
| DK1367062T3 (da) | Ny fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf | |
| SE0200579D0 (sv) | Device and method for thrombolysis | |
| SE0301582D0 (sv) | Förfarande vid telekommunikation jämte anordning |